Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06444360
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-05
First Post:
2024-05-30
Brief Title:
Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Young GayBisexual Minority Men IMPACT
Sponsor:
Westat
Organization:
Westat
Study Overview
Official Title:
Hybrid Type 2 Effectiveness-Implementation Trial of Status Neutral Integrated Behavioral Activation and Risk Reduction Intervention for Stimulant Use Among Sexually Active Young GayBisexual Sexual Minority Men Project IMPACT
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IMPACT
Brief Summary:
The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk
Detailed Description:
IMPACT is a Human Immunodeficiency Virus HIV status-neutral behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk This study will evaluate the effectiveness of IMPACT and determine feasibility of implementing IMPACT across various settings for translation into real-world practice using a hybrid effectiveness-implementation design
The IMPACT intervention includes 10 sessions 2 intervention sessions of HIV risk reduction RR 1 session focused on orienting and rationale of behavioral activation BA 6 sessions integrating BA and RR-including pre-exposure prophylaxis PrEP or antiretroviral therapy ART and HIV care-and 1 final session on relapse prevention
The enhanced Standard of Care eSOC group includes two HIV RR intervention sessions
The IMPACT intervention includes 10 sessions 2 intervention sessions of HIV risk reduction RR 1 session focused on orienting and rationale of behavioral activation BA 6 sessions integrating BA and RR-including pre-exposure prophylaxis PrEP or antiretroviral therapy ART and HIV care-and 1 final session on relapse prevention
The enhanced Standard of Care eSOC group includes two HIV RR intervention sessions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None